288251-87-6 Usage
Uses
Used in Academic Research:
Tert-Butyl 4-(2-cyano-4-nitrophenyl)piperazine-1-carboxylate is used as a research chemical for studying its structural properties and potential interactions with biological receptors. Its unique combination of functional groups allows researchers to explore its binding affinity and selectivity, which can contribute to the development of new pharmacological agents.
Used in Industrial Research:
In the industrial sector, Tert-Butyl 4-(2-cyano-4-nitrophenyl)piperazine-1-carboxylate serves as a precursor or intermediate in the synthesis of more complex molecules with potential applications in various fields. Its presence in the piperazine class of chemicals makes it a valuable component in the development of new drugs and other chemical products.
Used in Pharmaceutical Development:
Although not yet widely applied, Tert-Butyl 4-(2-cyano-4-nitrophenyl)piperazine-1-carboxylate holds promise for use in the pharmaceutical industry. Its ability to bind to various receptors may lead to the discovery of new therapeutic agents with novel mechanisms of action. Further research is needed to fully understand its potential applications and optimize its properties for specific medical uses.
Check Digit Verification of cas no
The CAS Registry Mumber 288251-87-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,8,2,5 and 1 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 288251-87:
(8*2)+(7*8)+(6*8)+(5*2)+(4*5)+(3*1)+(2*8)+(1*7)=176
176 % 10 = 6
So 288251-87-6 is a valid CAS Registry Number.
288251-87-6Relevant academic research and scientific papers
AMIDE COMPOUNDS AND MEDICINAL USE THEREOF
-
Page 57, (2010/01/31)
The present invention relates to a compound of the formula wherein R1 is substituted aryl, heteroaryl and the like, R2 and R3 are hydrogen, alkyl, halogen, hydroxyl group and the like, Q is N, CH and the like, W is hydrogen, alkyl, hydroxycarbonylalkyl and the like, X is halogen, cyano, nitro, amino and the like, X' is hydrogen, halogen, cyano, nitro, and Y is alkyl, hydroxyl group, alkoxy, mercapto and the like and a salt thereof, and a medicine containing the said compound. The compound of the present invention shows a superior inhibitory effect on activated lymphocytes proliferation and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.